Relative risk reduction versus number needed to treat as measures of lipid-lowering trial results

被引:7
|
作者
Moriarty, PM [1 ]
机构
[1] Univ Kansas, Med Ctr, Lipid Arteriosclerosis & Metab Clin, Kansas City, KS 66103 USA
来源
AMERICAN JOURNAL OF CARDIOLOGY | 1998年 / 82卷 / 04期
关键词
D O I
10.1016/S0002-9149(98)00367-1
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Recent clinical trials dealing with cholesterol reduction in primary and secondary prevention for cardiovascular disease use Relative Risk Reduction to assess their clinical outcomes, Number Needed to Treat is a more valid measurement.
引用
收藏
页码:505 / +
页数:4
相关论文
共 50 条